查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1306217

濫用藥物測試市場：結構要素（分析儀器、消耗品、實驗室服務）、按樣本類型（血液、頭髮、口腔液）、按最終用戶 - 2023-2030 年全球預測

Drug of Abuse Testing Market by Component (Analyzers, Consumables, Laboratory Services), Sample Type (Blood, Hair, Oral Fluids), End User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年全球藥物濫用檢測市場將大幅成長，達到17.4895億美元，複合年成長率為7.26%，2030年將達到28.6077億美元。

FPNV定位矩陣

FPNV 定位矩陣對於評估全球濫用藥物測試市場至關重要。通過檢查業務戰略和產品滿意度的關鍵指標，我們對供應商進行全面評估，使用戶能夠根據自己的具體需求做出資訊的決策。這種高級分析將供應商分為四個像限，並取得了不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析可以深入了解供應商在特定市場領域的當前地位。比較供應商對總收入、基本客群和其他關鍵指標的貢獻，可以幫助公司更好地了解他們在爭奪市場佔有率時的表現以及面臨的情況。該分析還揭示了特定行業的競爭程度、積累和合併的優勢以及研究基準年的合併特徵。

本報告提供了以下幾點見解：

1. 市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2. 市場開發：提供有關利潤豐厚的新興市場的詳細資訊，並分析其在成熟市場的滲透率。

3. 市場多元化：提供有關新產品發布、未開發領域、最新發展和投資的詳細資訊。

4.市場趨勢：全面了解COVID-19、俄羅斯-烏克蘭衝突和高通貨膨脹的累積影響。

5、競爭評估與資訊：對主要企業的市場佔有率、戰略、產品、認證、法規狀況、專利狀況、製造能力等進行綜合評價。

6. 產品開發和創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告回答了以下問題：

1. 濫用藥物檢測的全球市場規模和預測是多少？

2.在預測期內，COVID-19 對全球濫用藥物檢測市場的抑制要素和影響是什麼？

3.在預測期內，全球濫用藥物測試市場需要投資哪些產品/細分市場/應用/領域？

4. 全球濫用藥物檢測市場的競爭策略是什麼？

5.全球濫用藥物檢測市場的技術趨勢和法律規範是什麼？

6.全球濫用藥物檢測市場主要供應商的市場佔有率是多少？

7. 哪些型態和戰略舉措被認為適合進入全球濫用藥物檢測市場？

目錄

第1章 前言

第2章 調查方法

第3章 執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 促進因素
      • 對藥物濫用治療的需求不斷成長
      • 嚴格的法律要求進行酒精和藥物測試
      • 與毒品相關的死亡率增加和政府的努力
    • 抑制因素
      • 在一些國家，藥物測試被視為侵犯隱私權
    • 機會
      • 介紹創新且易於使用的拋棄式產品
      • 藥物檢測技術進步
    • 任務
      • 假陽性測試的可能性
  • 市場趨勢
  • COVID-19 的累積影響
  • 俄羅斯-烏克蘭衝突的累積影響
  • 高通貨膨脹的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範
  • 客戶客製化

第6章 濫用藥物測試市場：按組成部分

  • 分析儀
  • 消耗品
  • 檢驗服務
  • 快速檢查裝置

第7章 按樣本類型分類的濫用藥物檢測市場

  • 血
  • 頭髮
  • 口腔液
  • 汗
  • 尿

第8章 濫用藥物測試市場：按最終用戶分類

  • 刑事司法系統和執法
  • 醫院
  • 調查
  • 職場和學校

第9章 美洲濫用藥物測試市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章 亞太藥物濫用檢測市場

  • 澳大利亞
  • 中國
  • 印度
  • 印度尼西亞
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲濫用藥物檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 競爭情景分析：主要企業

第13章上市公司名單

第14章附錄

  • 討論指南
  • 關於許可和定價
Product Code: MRR-4348D129FA92

The Global Drug of Abuse Testing Market is forecasted to grow significantly, with a projected USD 1,748.95 million in 2023 at a CAGR of 7.26% and expected to reach a staggering USD 2,860.77 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Drug of Abuse Testing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Drug of Abuse Testing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Component, market is studied across Analyzers, Consumables, Laboratory Services, and Rapid Testing Devices. The Rapid Testing Devices is projected to witness significant market share during forecast period.

Based on Sample Type, market is studied across Blood, Hair, Oral Fluids, Sweat, and Urine. The Sweat is projected to witness significant market share during forecast period.

Based on End User, market is studied across Criminal Justice Systems & Law Enforcement Agencies, Hospitals, Research Laboratories, and Workplace & School. The Hospitals is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Drug of Abuse Testing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Drug of Abuse Testing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Drug of Abuse Testing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Drug of Abuse Testing Market?

4. What is the competitive strategic window for opportunities in the Global Drug of Abuse Testing Market?

5. What are the technology trends and regulatory frameworks in the Global Drug of Abuse Testing Market?

6. What is the market share of the leading vendors in the Global Drug of Abuse Testing Market?

7. What modes and strategic moves are considered suitable for entering the Global Drug of Abuse Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Drug of Abuse Testing Market, by Component, 2022 vs 2030
  • 4.3. Drug of Abuse Testing Market, by Sample Type, 2022 vs 2030
  • 4.4. Drug of Abuse Testing Market, by End User, 2022 vs 2030
  • 4.5. Drug of Abuse Testing Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for drug abuse treatment
      • 5.1.1.2. Stringent law mandating alcohol and drug testing
      • 5.1.1.3. Increasing drug-related mortality rate and government initiative
    • 5.1.2. Restraints
      • 5.1.2.1. Drug testing is recognized as a violation of privacy rights in some countries
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction to innovative and user-friendly disposable products
      • 5.1.3.2. Technological advancements in drug testing
    • 5.1.4. Challenges
      • 5.1.4.1. Possibilities of false-positive test
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Drug of Abuse Testing Market, by Component

  • 6.1. Introduction
  • 6.2. Analyzers
  • 6.3. Consumables
  • 6.4. Laboratory Services
  • 6.5. Rapid Testing Devices

7. Drug of Abuse Testing Market, by Sample Type

  • 7.1. Introduction
  • 7.2. Blood
  • 7.3. Hair
  • 7.4. Oral Fluids
  • 7.5. Sweat
  • 7.6. Urine

8. Drug of Abuse Testing Market, by End User

  • 8.1. Introduction
  • 8.2. Criminal Justice Systems & Law Enforcement Agencies
  • 8.3. Hospitals
  • 8.4. Research Laboratories
  • 8.5. Workplace & School

9. Americas Drug of Abuse Testing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Drug of Abuse Testing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Drug of Abuse Testing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DRUG OF ABUSE TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. DRUG OF ABUSE TESTING MARKET SIZE, 2022 VS 2030
  • FIGURE 3. DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
  • FIGURE 5. DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2030 (%)
  • FIGURE 6. DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 7. DRUG OF ABUSE TESTING MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. DRUG OF ABUSE TESTING MARKET DYNAMICS
  • FIGURE 9. DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. DRUG OF ABUSE TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. DRUG OF ABUSE TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 5. DRUG OF ABUSE TESTING MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. DRUG OF ABUSE TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DRUG OF ABUSE TESTING MARKET SIZE, BY LABORATORY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DRUG OF ABUSE TESTING MARKET SIZE, BY RAPID TESTING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 10. DRUG OF ABUSE TESTING MARKET SIZE, BY BLOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. DRUG OF ABUSE TESTING MARKET SIZE, BY HAIR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. DRUG OF ABUSE TESTING MARKET SIZE, BY ORAL FLUIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. DRUG OF ABUSE TESTING MARKET SIZE, BY SWEAT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. DRUG OF ABUSE TESTING MARKET SIZE, BY URINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. DRUG OF ABUSE TESTING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. DRUG OF ABUSE TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. DRUG OF ABUSE TESTING MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. DRUG OF ABUSE TESTING MARKET SIZE, BY WORKPLACE & SCHOOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM DRUG OF ABUSE TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. DRUG OF ABUSE TESTING MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 148. DRUG OF ABUSE TESTING MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 149. DRUG OF ABUSE TESTING MARKET LICENSE & PRICING